CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes...
Samsara, Dave Turn Highly Profitable as Specialty US Stocks Navigate 2026 Strategic Shifts
CDT Equity holds 20% stake in Sarborg after subscribing for 1,020 shares
CDT Equity Inc trading halted, news pending
12 Health Care Stocks Moving In Thursday's Pre-Market Session
CDT Equity announces 1-for-10 reverse stock split to maintain Nasdaq listing compliance
CDT Equity Q1 FY26 net loss narrows 14.52% to $4.06 million